BRISTOLMYERSDRNBRISTOLMYERSDRNBRISTOLMYERSDRN

BRISTOLMYERSDRN

No trades
See on Supercharts
Market capitalization
‪534.46 B‬BRL
0.01BRL
‪−48.24 B‬BRL
‪260.38 B‬BRL
Beta (1Y)
−0.59

About Bristol-Myers Squibb Company


CEO
Christopher S. Boerner
Website
Headquarters
Princeton
Founded
1933
ISIN
BRBMYBBDR000
FIGI
BBG0025NPDT2
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Check out other big names from the same industry as BMYB34.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BMY5007346
Bristol-Myers Squibb Company 3.45% 15-NOV-2027
Yield to maturity
Maturity date
Nov 15, 2027
BMY4831824
Bristol-Myers Squibb Company 3.4% 26-JUL-2029
Yield to maturity
Maturity date
Jul 26, 2029
BMY5009253
Bristol-Myers Squibb Company 4.625% 15-MAY-2044
Yield to maturity
Maturity date
May 15, 2044
BMY4926518
Bristol-Myers Squibb Company 3.45% 15-NOV-2027
Yield to maturity
Maturity date
Nov 15, 2027
BMY4945645
Bristol-Myers Squibb Company 3.9% 20-FEB-2028
Yield to maturity
Maturity date
Feb 20, 2028
C
BMY4124214
Celgene Corporation 4.625% 15-MAY-2044
Yield to maturity
Maturity date
May 15, 2044
BMY5007348
Bristol-Myers Squibb Company 5.7% 15-OCT-2040
Yield to maturity
Maturity date
Oct 15, 2040
BMY5009250
Bristol-Myers Squibb Company 4.55% 20-FEB-2048
Yield to maturity
Maturity date
Feb 20, 2048
BMY5007349
Bristol-Myers Squibb Company 5.25% 15-AUG-2043
Yield to maturity
Maturity date
Aug 15, 2043
BMY5009254
Bristol-Myers Squibb Company 4.25% 26-OCT-2049
Yield to maturity
Maturity date
Oct 26, 2049
BMY5754772
Bristol-Myers Squibb Company FRN 20-FEB-2026
Yield to maturity
Maturity date
Feb 20, 2026

See all BMYB34 bonds